ReviewLight, science & applications2026
Red OLED with efficiency of 25.6% at 10,000 cd m
Review in Light, science & applications, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- One Molecular Platform, Three Distinct Narrowband Organoboron TADF Emitters: A Divergent One-Pot Strategy From Green to Red.Angewandte Chemie (International ed. in English) · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
Abstract
Multiple resonance thermally activated delayed fluorescence (MR-TADF) materials featuring narrowband emission and high luminescence efficiency hold great promise for ultra-high-definition displays. However, red MR emitter-based organic light-emitting diodes (OLEDs) commonly suffer from pronounced efficiency roll-off due to intrinsically slow reverse intersystem crossing (RISC), which severely hinders their practical application. Herein, we present efficient OLEDs based on a selenium-embedded red MR framework featuring fast RISC, which not only serves as a high-performance emitter but also functions as a sensitizer. The emitter (tFSeBN) shows red emission at 607 nm and achieves a record-high RISC rate of 7.5 × 10
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.